More Related Content
Similar to Ppt chapter 26-1
Similar to Ppt chapter 26-1 (20)
More from stanbridge (20)
Ppt chapter 26-1
- 2. Pain
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Definition
– Sensory and emotional experience associated with
actual or potential tissue damage
• Drugs Used to Relieve Pain
– Narcotics: Opium derivatives used to treat many
types of pain
– Antimigraine Drugs: Reserved for the treatment of
migraine headaches
- 3. Neural Pathways of Pain
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 4. Gate-Control Theory of Pain
• Sensory and emotional experience
• Transmission of these impulses can be modulated or
adjusted
• Interneurons can act as “gates”
• Several factors, including learned experiences, cultural
expectations, individual tolerance, and the placebo effect,
can activate the descending inhibitory nerves from the
upper central nervous system
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 5. Location of Opioid Receptors
• CNS
• Nerves in the periphery
• Cells in the gastrointestinal (GI) tract
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 6. Narcotic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Act at specific opioid receptor sites in the CNS
– Produce analgesia, sedation, and a sense of well-being
• Indications
– Relief of severe acute or chronic pain
– Analgesia during anesthesia
– Cross placenta
- 7. Narcotic Agonists (cont.)
• Pharmacokinetics
– IV most reliable way to achieve therapeutic response
– IM and sub-q rate of absorption varies
– Hepatic metabolism and generally excreted in the
urine and bile
• Contraindications
– Known allergy
– Pregnancy, labor, lactation
– Diarrhea caused by poisons
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 8. Narcotic Agonists (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Cautions
– Respiratory dysfunction
– GI or GU surgery
– Acute abdomen or ulcerative colitis
• Adverse Reactions
– Respiratory depression with apnea
– Cardiac arrest
- 9. Narcotic Agonists (cont.)
• Adverse Reactions (cont.)
– Shock
– Orthostatic hypotension
– Nausea, vomiting, constipation
– Biliary spasm
– Dizziness, psychoses, anxiety, fear, hallucinations
• Drug-to-Drug Interactions
– Barbiturate general anesthetics, phenothiazines, and
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
MAOIs
- 10. Question
Identify a reason a narcotic agonist may be prescribed?
A. Relief of minor pain
B. Analgesia during anesthesia
C. Analgesia during sleep
D. Relief of moderate acute pain
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 11. Answer
b. Analgesia during anesthesia
Rationale: Indications:
– Relief of severe acute or chronic pain
– Analgesia during anesthesia
– Cross placenta
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 12. Narcotic Agonists–Antagonists
• Buprenorphine (Buprenex)
– Treats mild to moderate pain
• Butorphanol (Stadol, Stadol NS)
– Preoperative medication
– Relieves moderate to severe pain
• Nalbuphine (Nubain)
– Treats moderate to severe pain
– Adjunct for general anesthesia
– Relieves pain during labor and delivery
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 13. Narcotic Agonists–Antagonists (cont.)
• Pentazocine (Talwin)
– Preferred drug for patients switched from parenteral
to oral forms after surgery or labor
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 14. Narcotic Agonists–Antagonists (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Act at a specific opioid receptor sites in the CNS to
produce analgesia, sedation, euphoria, and
hallucinations
• Indications
– Moderate to severe pain
– Adjunct to general anesthesia
– Relief of pain during labor and delivery
- 15. Narcotic Agonists–Antagonists (cont.)
• Pharmacokinetics
– Readily absorbed IM and reach peak levels when
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
given IV
– Metabolized in the liver excreted in urine or feces
– Cross placenta
• Contraindications
– Known allergy
– Pregnancy and lactation
- 16. Narcotic Agonists–Antagonists (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Cautions
– Physical dependence on a narcotic
– COPD and disease of the respiratory tract
– Acute MI or documented CAD
• Adverse Reactions
– Respiratory depression
– Nausea, vomiting, constipation, and biliary spasm
- 17. Narcotic Agonists–Antagonists (cont.)
• Adverse Reactions
– Headache
– Dizziness
– Psychoses
– Anxiety
– Hallucinations
– Ureteral spasm, urinary retention
• Drug-to-Drug Interactions
– Barbiturate general anesthetics
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 18. Narcotic Antagonists
• Nalmefene (Revex)
– Reverses the effects of narcotics; manages known or
suspected narcotic overdose
• Naloxone (Narcan)
– Reverses adverse effects of narcotics; diagnoses
suspected acute narcotic overdose
• Naltrexone (ReVia)
– Used orally in the management of alcohol or narcotic
dependence
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 19. Narcotic Antagonists (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Drugs that bind strongly to opioid receptors, but they
do not activate the receptors
– Reverse effects of opioids
• Indications
– Reversal of the adverse effects of narcotics
– Treat narcotic and/or alcoholic dependence
- 20. Narcotic Antagonists (cont.)
• Pharmacokinetics
– Well absorbed after injection and are widely
distributed in the body
– Hepatic metabolism and excreted in the urine
– Enter breast milk
• Contraindications
– Known allergy
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 21. Narcotic Antagonists (cont.)
• Adverse Reactions
– Tachycardia
– Blood pressure changes
– Dysrhythmias
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 22. Narcotic Antagonists (cont.)
• Drug-to-Drug Interactions
– Reverse Effects on:
• Buprenorphine
• Butorphanol
• Nalbuphine
• Pentazocine
• Propoxyphene
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 23. Question
Identify one indicator for a narcotic antagonist to be
prescribed?
A. Treatment of alcohol independence
B. Reversal of bronchoconstriction
C. Treatment of narcotic dependence
D. Reversal of tachycardia
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 24. Answer
C. Treatment of narcotic dependence
Rationale: Indications
– Reversal of the adverse effects of narcotics
– Treat narcotic and/or alcoholic dependence
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 25. Headaches
• Migraine Headaches
– Severe, throbbing headaches on one side of the head
• Cluster Headaches
– Begin during sleep; involve sharp, steady eye pain,
sweating, flushing, tearing, and nasal congestion
• Tension Headaches
– Usually occur at times of stress; dull band of pain
around the entire head
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 26. Ergot Derivatives
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Block alpha-adrenergic and serotonin receptor sites
in the brain to cause constriction of cranial vessels
• Indications
– Prevention or abortion or migraine or vascular
headaches
- 27. Ergot Derivatives (cont.)
• Pharmacokinetics
– Rapidly absorbed from many routes
– Onset of action range from 15-30 minutes
– Metabolized in the liver and primarily excreted in the
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
bile
– Excreted in breast milk
- 28. Ergot Derivatives (cont.)
• Contraindications
– Known allergy
– Pregnancy or lactation
– CAD
– HTN
– PVD
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Cautions
– Pruitus
– Malnutrition
- 29. Ergot Derivatives (cont.)
• Adverse Reactions
– Numbness
– Tingling of extremities
– Muscle pain
– Pulselessness
– Weakness
– Chest pain
– Arrhythmias
– Nausea
– Vomiting
– Diarrhea
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 30. Ergot Derivatives (cont.)
• Drug-to-Drug Interactions
– Beta blockers
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 31. Triptans
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Bind to selective serotonin receptors sites to cause
vasoconstriction of cranial vessels
• Indications
– Treatment of acute migraine and are not used for
prevention of migraines
- 32. Triptans (cont.)
• Pharmacokinetics
– Rapidly absorbed from many sites
– Metabolized in the liver
– Primarily excreted in the urine
– Cross the placenta and enter breast milk
• Contraindications
– Known allergy, pregnancy, CAD
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 33. Triptans (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Cautions
– Elderly, risk factors for CAD, and lactation
• Adverse Reactions
– Numbness, tingling, burning sensation, feeling of
coldness, weakness, dysphasia, blood pressure
alterations
• Drug-to-Drug Interactions
– Ergot – containing drugs
– MAOI’s
- 34. Use of Narcotics and Antimigraine Agents Across
the Lifespan
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 42. Question
What is an action of Ergotamine?
A. Decreases hyperfusion of basilar artery vascular bed
B. Increases hyperfusion of basilar artery vascular bed
C. Increases hypoperfusion of basilar artery vascular bed
D. Decreases hypoperfusion of basilar artery vascular bed
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 43. Answer
A. Decreases hyperfusion of basilar artery vascular bed
Rationale: Actions: Constricts cranial blood vessels,
decreases pulsation of cranial arteries, and decreases
hyperfusion of basilar artery vascular bed; mechanism of
action is not understood
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 44. Nursing Considerations for Narcotic Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 45. Nursing Considerations for Narcotic Agonists–
Antagonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 46. Nursing Considerations for Narcotic Antagonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 47. Nursing Considerations for Ergot Derivatives
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 48. Nursing Considerations for Triptans
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 49. Question
The nurse is caring for a patient with Parkinson’s disease.
While writing the care plan for this patient what would be
an appropriate nursing diagnosis?
A. Constipation related to dopaminergic effects
B. Diarrhea related to dopaminergic effects
C. Risk for injury related to CVS effects and incidence of
orthostatic hypotension
D. Risk for injury related to CVS effects and incidence of
PVD
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 50. Answer
A. Constipation related to dopaminergic effects
Rationale: Nursing diagnoses related to drug therapy might
include: Constipation related to dopaminergic effects;
Risk for injury related to CNS effects and incidence of
orthostatic hypertension
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins